APA (7th ed.) Citation

Nazarov, V. D., Lapin, S. V., Dobronravov, V. A., Smirnov, K. A., Mayer, D. A., Muzhetskaya, T. O., & Totolian, A. A. (2018). CIRCULATING ANTIBODIES TO ERYTHROPOIETIN ARE ASSOCIATED WITH LOWER EFFICACY OF RECOMBINANT EPOETIN TREATMENT IN PATIENTS UNDERGOING HAEMODIALYSIS. SPb RAACI.

Chicago Style (17th ed.) Citation

Nazarov, V. D., S. V. Lapin, V. A. Dobronravov, K. A. Smirnov, D. A. Mayer, T. O. Muzhetskaya, and A. A. Totolian. CIRCULATING ANTIBODIES TO ERYTHROPOIETIN ARE ASSOCIATED WITH LOWER EFFICACY OF RECOMBINANT EPOETIN TREATMENT IN PATIENTS UNDERGOING HAEMODIALYSIS. SPb RAACI, 2018.

MLA (8th ed.) Citation

Nazarov, V. D., et al. CIRCULATING ANTIBODIES TO ERYTHROPOIETIN ARE ASSOCIATED WITH LOWER EFFICACY OF RECOMBINANT EPOETIN TREATMENT IN PATIENTS UNDERGOING HAEMODIALYSIS. SPb RAACI, 2018.